CIK 0001549595
- Large accelerated filer
Nurix Therapeutics, Inc.
Sign in to watch- Ticker
- NRIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Nov 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270838048
- Phone
- +1 415-660-5320
- Business address
- 1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
- Former names
- Nurix, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale General Counsel sold 1,200 shares at $27.00 ($32,400)
- 4 Open-market sale Chief Business Officer sold 7,500 shares at an average $26.49 ($198,644)
- 4 Other disposition 10% owner disposed of 1,085,784 shares (other)
- 4 Other disposition 10% owner disposed of 3,488,027 shares (other)
- 4 Other disposition 10% owner disposed of 3,488,027 shares (other)
- 4 Open-market sale Chief Scientific Officer sold 800 shares at $35.00 ($27,996)
- 4 Open-market sale General Counsel sold 800 shares at $35.25 ($28,200)
- 4 Open-market sale General Counsel sold 1,200 shares at $27.20 ($32,640)
- 4 Open-market sale Chief Business Officer sold 7,500 shares at an average $27.28 ($204,632)
- 4 Open-market sale Chief Scientific Officer sold 400 shares at $35.00 ($14,000)
- 4 Open-market sale Chief Scientific Officer sold 400 shares at $31.55 ($12,620)
- 4 Exercise or conversion Chief Business Officer acquired 4,330 shares (option exercise)
- 4 Open-market sale Chief Scientific Officer sold 800 shares at $45.00 ($36,000)
- 4 Open-market sale General Counsel sold 2,000 shares at an average $41.27 ($82,539)
- 4 Open-market sale Chief Business Officer sold 7,500 shares at an average $37.02 ($277,678)
- 4 Open-market sale Chief Scientific Officer sold 800 shares at $35.95 ($28,760)
- 4 Open-market sale Chief Financial Officer sold 35,419 shares at $39.90 ($1,413,218)
- 4 Open-market sale Chief Financial Officer sold 5,330 shares at $39.93 ($212,839)
Page 12 of 14 · 274 filings